Bart Friedman

Lead Independent Director at Ovid Therapeutics

Bart Friedman, J.D., has been a member of Ovid’s board of directors since November 2015. Mr. Friedman was a partner at Cahill Gordon & Reindel LLP, a New York law firm, from 1980 through 2017, when he became senior counsel. Mr. Friedman’s practice focuses on corporate governance investigations and advisory and crisis advisory. Earlier in his career, Mr. Friedman worked at the Securities and Exchange Commission and acted as a liaison to other departments in the government. Mr. Friedman has served as chairman of the board of directors of the Sanford C. Bernstein Mutual Funds and as the lead director of the board of directors of Allied World Assurance Company Holdings, AG (NYSE: AWH), a publicly held company. He currently serves as chair of the audit committee of the Brookings Institution, chair of the audit committee of Lincoln Center for the Performing Arts and as chair of the Guggenheim Museum’s Works and Process Program. Mr. Friedman has also served as vice chair of the Juilliard School and as a member of the Visiting Committee of Harvard’s Graduate School of Education. Mr. Friedman is an active member of the Council on Foreign Relations (CFR) and serves on the membership committee of the Council. He has also served as a member of Council on Foreign Relations delegations to many countries and institutions, including Saudi Arabia, Egypt, Lybia, Turkey, and NATO among others. He has also served as a member of CFR Task Forces on issues ranging from nonlethal weaponry to resources for foreign aid. Mr. Friedman earned his Bachelor of Arts from Long Island University and his Juris Doctor from Harvard Law School. He also served as a research associate at Harvard Business School.

Timeline

  • Lead Independent Director

    Current role

  • Director